Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 11 of 11

List	Outcome	Time frame	Description
Primary	alveolar-arterial oxygen gradient in mmHg	3 months
Secondary	presence of HPS	3 months	assessment via contrast enhanced transthoracic echocardiography and pulmonary function testing
Secondary	6 minutes walking distance in m	3 months
Secondary	WHO functional class	3 months
Secondary	quality of life	3 months	we will us the CAT-questionaire for QoL assessment
Secondary	aminotransferase level (ASAT, ALAT)	3 months	Assessment of the aminotransferase levels in U/L
Secondary	exhanled nitric oxide in parts per billion	3 months
Secondary	hepatic venous pressure gradient (HVPG) in mmHg	3 months	HVPG will be assessed after inclusion in the study and after 3 months
Secondary	pulmonary hemodynamics	3 months	pulmonary hemodynamics will be assessed after inclusion and after 3 months
Secondary	mean arterial blood pressue in mmHg	3 months
Secondary	partial pressure of arterial oxygen in mmHg	3 months

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01518595/registered